Skip to Main Content

Author Details

Genevi??ve Deblois
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
2003
33
21
PMIDPaper TitleJournal TitlePublished Year
36587133Profiling the Epigenetic Landscape of the Tumor Microenvironment Using Chromatin Immunoprecipitation Sequencing.Methods Mol Biol2023
37020039Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer.Oncogene2023
360373423D chromatin remodeling potentiates transcriptional programs driving cell invasion.Proc Natl Acad Sci U S A2022
35578032PRMT inhibition induces a viral mimicry response in triple-negative breast cancer.Nat Chem Biol2022
33470989p66ShcA potentiates the cytotoxic response of triple-negative breast cancers to PARP inhibitors.JCI Insight2021
34572926Metabolic Flexibility Is a Determinant of Breast Cancer Heterogeneity and Progression.Cancers (Basel)2021
32546577Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer.Cancer Discov2020
32966787Bisphosphoglycerate Mutase Deficiency Protects against Cerebral Malaria and Severe Malaria-Induced Anemia.Cell Rep2020
32445698Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.Cell2020
29921600Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities.J Cell Biol2018
27402251ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer.Nat Commun2016
27391063Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network.Oncotarget2016
27498878The Transcriptional Repressor Polycomb Group Factor 6, PCGF6, Negatively Regulates Dendritic Cell Activation and Promotes Quiescence.Cell Rep2016
24379448Prostate cancer genetic-susceptibility locus on chromosome 20q13 is amplified and coupled to androgen receptor-regulation in metastatic tumors.Mol Cancer Res2014
25246633ERBB2 deficiency alters an E2F-1-dependent adaptive stress response and leads to cardiac dysfunction.Mol Cell Biol2014
23192231Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond.Nat Rev Cancer2013
24304688PGC-1α supports glutamine metabolism in breast cancer.Cancer Metab2013
23720052β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.Cancer Res2013
23208510The PGC-1/ERR signaling axis in cancer.Oncogene2013
22258604Cancer: Reprogramming clinical outcome.Nature2012
22282656PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer.Cancer Res2012
21172432Functional and physiological genomics of estrogen-related receptors (ERRs) in health and disease.Biochim Biophys Acta2011
22179984Estrogen-related receptor α, the molecular clock, and transcriptional control of metabolic outputs.Cold Spring Harb Symp Quant Biol2011
20484414An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha.Mol Endocrinol2010
20961995Transcriptional control of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary gland tumorigenesis.Cancer Res2010
19622763Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.Cancer Res2009
18292239Nuclear receptor location analyses in mammalian genomes: from gene regulation to regulatory networks.Mol Endocrinol2008
16606704Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression.Genome Res2006
16087863From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.Proc Natl Acad Sci U S A2005
15831516Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.Mol Endocrinol2005
15466464Estrogen-related receptor alpha (ERRalpha) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine.J Biol Chem2004
14631854Nuclear receptor target gene discovery using high-throughput chromatin immunoprecipitation.Methods Enzymol2003
12943696Ligand-independent coactivation of ERalpha AF-1 by steroid receptor RNA activator (SRA) via MAPK activation.J Steroid Biochem Mol Biol2003
  • 1 - 33 of 33

Recommended Authors

Yunpeng Gao
University of Texas Southwestern Medical Center at Dallas
Career Start Year 2017
Number of shared co-authors 2
Matthew Ung
Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth
Career Start Year 2013
Number of shared co-authors 0
Jeffery M Vahrenkamp
Huntsman Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Rahul K Kollipara
McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 1
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 3
Dimple Chakravarty
Icahn School of Medicine at Mount Sinai
Career Start Year 2007
Number of shared co-authors 1
Anna V??h??rautio
University of Helsinki
Career Start Year 2006
Number of shared co-authors 0
Tianyuan Wang
National Institute of Environmental Health Sciences, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 1
Wilbert Zwart
Oncode Institute, The Netherlands Cancer Institute
Career Start Year 2004
Number of shared co-authors 10
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 2
Jason Gertz
Huntsman Cancer Institute, University of Utah
Career Start Year 2003
Number of shared co-authors 2
Joshua D Stender
University of California San Diego
Career Start Year 2003
Number of shared co-authors 0
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 8
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 0
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Tesa M Severson
Oncode Institute, The Netherlands Cancer Institute
Career Start Year 2002
Number of shared co-authors 10
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Anupama E Gururaj
National Institute of Allergy and Infectious Disease, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Liewei Wang
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 0
Tim H-M Huang
University of Texas Health San Antonio (UTHSA)
Career Start Year 1997
Number of shared co-authors 2
Ian G Mills
Queen's University Belfast
Career Start Year 1997
Number of shared co-authors 2
Cecilia Williams
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 0
Rong Li
University of Texas Health
Career Start Year 1989
Number of shared co-authors 0
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 1
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year 1984
Number of shared co-authors 2
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Career Start Year 1983
Number of shared co-authors 3
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 2
Christopher C Benz
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 0

Collaborators

Mathieu Lupien
Princess Margaret Cancer Research Centre
Co-authored papers 7
Cheryl H Arrowsmith
University of Toronto
Co-authored papers 4
Michel L Tremblay
Co-authored papers 3
Daniel D De Carvalho
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Seyed Ali Madani Tonekaboni
Princess Margaret Cancer Research Centre
Co-authored papers 2
Swneke D Bailey
Research Institute of the McGill University Health Centre
Co-authored papers 2
David W Cescon
Princess Margaret Cancer Centre
Co-authored papers 2
Jason W Locasale
Duke University
Co-authored papers 2
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Celine Lefebvre
The Scripps Research Institute
Co-authored papers 2
Jennifer Cruickshank
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Alex Murison
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Dalia Barsyte-Lovejoy
University of Toronto, College St
Co-authored papers 2
Fran??ois Robert
Institut de recherches cliniques de Montreal
Co-authored papers 2
Wail Ba-Alawi
Princess Margaret Cancer Centre, University Health Network, University Ave.
Co-authored papers 2
Paul Guilhamon
The Hospital for Sick Children
Co-authored papers 2
Sachin A Kumar
University of Toronto
Co-authored papers 1
Guillaume Bourque
Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University
Co-authored papers 1
Joshua D Rabinowitz
Lewis Sigler Institute for Integrative Genomics, Princeton University
Co-authored papers 1
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Co-authored papers 1
Florence M G Cavalli
Institut Curie, PSL Research University
Co-authored papers 1
Stanley Zhou
Princess Margaret Cancer Research Centre
Co-authored papers 1
Maxime Caron
Centre Hospitalier Universitaire Sainte-Justine
Co-authored papers 1
Sameer Agnihotri
Co-authored papers 1
Kyle Juraschka
The Hospital for Sick Children, University of Toronto
Co-authored papers 1
Hui Fang
Beihua University
Co-authored papers 1
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
Benjamin A Garcia
University of Pennsylvania
Co-authored papers 1
Graham MacLeod
University of Toronto
Co-authored papers 1
Lincoln Stein
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 1
Release 1.2